Bringing a sterile injectable product from development to commercialization requires a seamless scale-up process—one that minimizes risk, optimizes efficiency, and ensures regulatory success. In this exclusive webinar, experts from August Bioservices will discuss the critical factors that make or break a successful scale-up, sharing insights from a CDMO’s unique perspective.

August Bioservices LLC has received $1 million in funding from the Tennessee Department of Economic and Community Development for machinery and additional staff. This is not the first or the last time the pharmaceutical company will be expanding.

The funding comes two months after August Bioservices completed the first stage of a $64.7 million campus expansion, which included a renovated commercial facility with sterile processing equipment and new laboratory instrumentation.